Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

GH gains ground with stronger guidance, improving margin and Reveal's breakout as TEM scales fast but stays unprofitable.

Discover how Nancy Pelosi and her husband, Paul Pelosi, achieved astonishing investment gains in 2024, outpacing major hedge ...

Nebius lags CoreWeave in scale but boasts strong cash, low leverage, and diversified growth across industries. Find out why ...

Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...

Visit a quote page and your recently viewed tickers will be displayed here.

Now we have a full house. Labour's spending review, the infrastructure plan and long-awaited industrial strategy.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Tempus AI, Inc. ("Tempus" or the "Company") (NASDAQ: TEM) common stock ...

DATROWAY® Approved in the U.S. as First TROP2 Directed Therapy for Patients with Previously Treated Advanced EGFR-Mutated Non ...

(Reuters) -AstraZeneca said on Tuesday that U.S. regulators have approved its precision drug Datroway to treat a type of lung ...

Innovent Biologics is pivoting to R&D and oncology growth in China, but high valuation and risks temper upside. Read why ...

Ever since June 2007, our Momentum Classics screen has tracked the performance of the FTSE 100’s biggest quarterly risers and ...